Medical News

RSS

Perrigo receives FDA OK for OTC Cetirizine Hydrochloride tablets

Perrigo Company has announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for over-the-counter (OTC) Cetirizine Hydrochloride Tablets, 5 and 10 mg.

2 Jan 2008

New therapy reduces mortality in patients with severe COPD

Patients with severe COPD may benefit more from therapy that combines salmeterol and fluticasone [SFC] than treatment with tiotropium, according to results from a long-term, multi-center study, "Investigating New Standards for Prophylaxis in Reducing Exacerbations" (INSPIRE) that directly compared the two therapies.

2 Jan 2008

Catathrenia, or sleep related groaning can be successfully treated with CPAP

Catathrenia, or sleep related groaning, is an uncommon feature of a sleep-related breathing disorder that can be successfully treated with continuous positive airway pressure (CPAP), according to a study published in the January 1 issue of the journal SLEEP.

2 Jan 2008

Cosmecueticals improve skin

Cosmecueticals, beauty aids that reportedly work like prescription drugs, are providing new ways to treat aging skin.

2 Jan 2008

Mylan announces FDA approval for Cetirizine Hydrochloride tablets

Mylan Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Tablets (OTC), 5 mg and 10 mg.

2 Jan 2008

Botox treatment for men

A review published in Dermatologic Therapy reveals that men can be treated with Botox for cosmetic procedures in the same way as women but require higher doses of Botox in all treatment areas.

2 Jan 2008

Marital status doesn't affect lung cancer survival

Contrary to previous studies, married patients with lung cancer do not have longer survival, according to analysis of an extensive Mayo Clinic database in the December issue of "The Oncologist."

2 Jan 2008

Study of high myopia patients ten years after LASIK surgery

Laser surgery to correct vision problems has been in use since the early 1990s.

2 Jan 2008

Deep sleep maintains normal glucose control

Suppression of slow-wave sleep in healthy young adults significantly decreases their ability to regulate blood-sugar levels and increases the risk of type 2 diabetes, report researchers at the University of Chicago Medical Center in the "Early Edition" of the Proceedings of the National Academy of Science, available online as soon as Dec. 31, 2007.

2 Jan 2008

New drug target for treatment-resistant prostate cancer

Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.

2 Jan 2008

Contact with commonly used pesticides associated with greater asthma risk in farm women

New research on farm women has shown that contact with some commonly used pesticides in farm work may increase their risk of allergic asthma.

2 Jan 2008

Gene variation increases risk of liver tumor in patients with cirrhosis

A particular gene variation appears to significantly increase the risk that individuals with cirrhosis of the liver will go on to develop hepatocellular carcinoma (HCC), a liver tumor that is the third leading cause of cancer death.

2 Jan 2008

A happy marriage bolsters a woman's physiological recovery from work

That's the suggestion from a new UCLA study that tracked levels of cortisol, a key stress hormone, among 30 Los Angeles married couples involved in one of our age's trickiest juggling acts - raising kids when both parents work full time.

2 Jan 2008

FASgen announces new discoveries in lung cancer

FASgen is pleased to report the publication of important research results for lung cancer treatment using FAS093, one of the Company's proprietary compounds.

2 Jan 2008

Ensuring heart safety of non-heart drugs

Current regulatory policies should be strengthened to ensure acceptable cardiovascular safety of drugs developed primarily for non-cardiovascular medical problems, according to a recent presentation made by Dr. Jeffrey Borer, an authority in cardiovascular medicine and surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City.

2 Jan 2008